2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours

Aapro, M.S.; Bohlius, J.; Cameron, D.A.; Lago, Lissandra Dal; Donnelly, J. Peter; Kearney, N.; Lyman, G.H.; Pettengell, R.; Tjan-Heijnen, V.C.; Walewski, J.; Weber, Damien C.; Zielinski, C.

doi:10.1016/j.ejca.2010.10.013

« Previous Next »European Journal of Cancer
Volume 47, Issue 1 , Pages 8-32, January 2011

2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours

M.S. Aapro
- Multidisciplinary Oncology Institute, Clinique de Genolier, 1, route du Muids, 1272 Genolier, Switzerland
- Corresponding author: Tel.: +41 22 366 9106; fax: +41 22 366 9131.
- Member of the EORTC Task Force Elderly.
J. Bohlius
- Institute of Social and Preventive Medicine, University of Bern, Switzerland
- Methodology Expert.
D.A. Cameron
- Department of Oncology, University of Edinburgh, Edinburgh, Scotland, UK
- Representative of the EORTC Breast Cancer Group.
Lissandra Dal Lago
- EORTC Headquarters, Av. E. Mounier 83, 1200 Brussels, Belgium
- Representative of the EORTC Headquarters.
J. Peter Donnelly
- Radboud University Nijmegen, Department of Medical Oncology, Nijmegen, The Netherlands
- Representative of the EORTC Infectious Disease Group.
N. Kearney
- School of Nursing and Midwifery, University of Dundee, 11 Airlie Place, Dundee, Scotland, UK
- Nursing Expert, mandated by EONS (European Oncology Nursing Society).
G.H. Lyman
- Duke University and Duke Comprehensive Cancer Center, Durham, NC, USA
- US Expert.
R. Pettengell
- Department of Haematology, St George’s Hospital, University of London, London, UK
- Member of the EORTC and Lymphoma Expert.
V.C. Tjan-Heijnen
- Maastricht University Medical Centre, Maastricht, The Netherlands
- Representative of the EORTC Lung Cancer Group.
J. Walewski
- The Maria Sklodowska-Curie Memorial Cancer Institute and Oncology Centre, Warszawa, Poland
- Representative of the EORTC Lymphoma Group.
Damien C. Weber
- Radiation Oncology, Geneva University Hospital, Geneva, Switzerland
- Central European Cooperative Oncology Group (www.cecog.org).
C. Zielinski
- Clinical Division of Oncology, Department of Medicine I, Medical University Vienna, Austria
- Representative of the EORTC Radiation Oncology Group.